"TRPV1 is a component of the atrial natriuretic signaling complex, and using orally delivered antagonists, presents a valid therapeutic target in the longitudinal reversal and treatment of cardiac hypertrophy and heart failure".

Name: "TRPV1 is a component of the atrial natriuretic signaling complex, and using orally delivered antagonists, presents a valid therapeutic target in the longitudinal reversal and treatment of cardiac hypertrophy and heart failure".
Author: Horton, Jaime S

"TRPV1 is a component of the atrial natriuretic signaling complex, and using orally delivered antagonists, presents a valid therapeutic target in the longitudinal reversal and treatment of cardiac hypertrophy and heart failure". — المؤلف: Horton, Jaime S — Channels (Austin, Tex.) 20191001

المؤلف: Horton, Jaime S
النشر: Channels (Austin, Tex.) 20191001
الوصف: 1-16 p.
الموضوعات: Acrylamides؛ Administration, Oral؛ Animals؛ Bridged Bicyclo Compounds, Heterocyclic؛ Cardiomegaly؛ HEK293 Cells؛ Heart Failure؛ Humans